RT Journal Article
T1 SEOM-GECOD clinical guideline for unknown primary cancer (2021).
A1 Losa, Ferrán
A1 Fernández, Isaura
A1 Etxaniz, Olatz
A1 Giménez, Alejandra
A1 Gomila, Paula
A1 Iglesias, Lara
A1 Longo, Federico
A1 Nogales, Esteban
A1 Sánchez, Antonio
A1 Soler, Gemma
K1 Cancer
K1 Diagnosis
K1 Treatment
K1 Unknown primary site
AB Cancer of unknown primary site (CUP) is defined as a heterogeneous group of tumors that appear as metastases, and of which standard diagnostic work-up fails to identify the origin. It is considered a separate entity with a specific biology, and nowadays molecular characteristics and the determination of actionable mutations may be important in a significant group of patients. In this guide, we summarize the diagnostic, therapeutic, and possible new developments in molecular medicine that may help us in the management of this unique disease entity.
YR 2022
FD 2022-03-23
LK http://hdl.handle.net/10668/21097
UL http://hdl.handle.net/10668/21097
LA en
DS RISalud
RD Apr 18, 2025